Selamectin (Revolution)

Selamectin, marketed under the brand name Revolution, is a macrocyclic lactone antiparasitic medication that has become widely utilized in avian medicine for the treatment and prevention of both external and internal parasitic infestations. Originally developed and approved for use in dogs and cats, selamectin has gained acceptance as an effective extra-label treatment option for pet birds due to its broad spectrum of activity, convenient topical application, and favorable safety profile when used appropriately in avian species. The medication belongs to the avermectin class of compounds and shares structural and mechanistic similarities with other macrocyclic lactones used in veterinary medicine, including ivermectin and moxidectin. Selamectin has proven particularly valuable in avian practice due to its ability to address multiple parasite types with a single, easy-to-administer topical application.

The mechanism of action of selamectin involves selective binding to glutamate-gated chloride channels found in nerve and muscle cells of invertebrate parasites. This binding leads to increased chloride ion permeability across cell membranes, causing hyperpolarization and subsequent paralysis and death of susceptible parasites. The selective toxicity of selamectin toward invertebrates relates to the fact that glutamate-gated chloride channels of this type are not present in vertebrates in the same form, providing a basis for the medication's relative safety in birds and mammals when used at appropriate doses. Following topical application, selamectin is absorbed through the skin and distributes throughout body tissues, providing systemic activity against parasites.

The topical spot-on formulation of selamectin offers significant practical advantages for avian use. The medication is applied to a small area of skin, typically on the back of the neck where the bird cannot preen it off, eliminating the need for oral administration or injection. This application method reduces handling stress and simplifies treatment compliance, as a single application provides extended protection. The lipophilic nature of selamectin allows it to persist in the skin and body tissues, providing ongoing activity against parasites for several weeks following application. Various concentration formulations are available, allowing veterinarians to select appropriate volumes for birds of different sizes.

The safety profile of selamectin in birds is generally considered favorable when the medication is used at appropriate doses under veterinary supervision. Clinical experience and published reports support its safe use across a variety of avian species, including psittacines and passerines. However, as with any medication, adverse effects are possible, and the importance of proper dosing cannot be overstated given the enormous size variation among bird species. Selamectin is a prescription medication that should only be used under the guidance of an avian veterinarian who can determine appropriate dosing for the individual bird and monitor for any treatment-related concerns. Self-medication of birds with products intended for other species can result in serious overdosing and should be avoided.

The primary indications for selamectin in avian medicine encompass the treatment and prevention of various external parasitic infestations, most notably mites and lice that commonly affect pet birds. Selamectin's broad spectrum of activity makes it a versatile choice for avian parasite management, capable of addressing multiple parasite types with a single treatment. The medication has become a preferred option among avian veterinarians for routine parasite control due to its efficacy, ease of administration, and established safety record. Many veterinarians utilize selamectin as a first-line treatment for ectoparasite infestations in pet birds.

Feather mites represent one of the most common targets for selamectin therapy in pet birds. These parasites inhabit the plumage and can cause significant irritation, excessive preening, feather damage, and general discomfort in affected birds. Selamectin's systemic distribution following topical application allows it to reach parasites throughout the feather coat, providing thorough treatment even of heavily infested birds. Clinical improvement is typically observed within days of treatment, with reduction in scratching and preening behaviors and gradual improvement in feather condition as damage grows out.

Air sac mites, particularly Sternostoma tracheacolum, constitute another important indication for selamectin use in birds. These internal parasites inhabit the respiratory system, including the trachea and air sacs, and can cause respiratory distress, voice changes, clicking sounds during breathing, and potentially fatal airway obstruction in severe cases. Small birds including finches, canaries, and Gouldian finches are particularly susceptible to air sac mite infestations. Selamectin's systemic activity allows it to reach parasites within the respiratory system, making it an effective treatment option for this potentially serious condition. Treatment may need to be repeated to ensure complete elimination of all life stages.

Lice infestations in birds also respond well to selamectin treatment. Avian lice are permanent ectoparasites that spend their entire life cycle on the host bird, feeding on feathers, skin debris, or blood depending on the species. Heavy lice burdens cause feather damage, skin irritation, and general unthriftiness, particularly affecting young, elderly, or immunocompromised birds. The prolonged activity of selamectin following application provides extended protection that helps eliminate lice through multiple life cycle stages, often achieving complete elimination with one or two treatments.

Selamectin may be selected over alternative antiparasitic agents based on several factors that make it particularly suitable for avian use. The ease of topical application minimizes handling stress and improves treatment compliance compared to oral or injectable medications. The broad spectrum of activity allows treatment of multiple parasite types simultaneously, simplifying management when birds have concurrent infestations or when specific parasite identification is uncertain. The extended duration of action reduces the frequency of treatment needed compared to products with shorter activity. These advantages make selamectin a practical and effective choice for many avian parasite control situations.

Dosing of selamectin in avian patients requires precise calculation based on the bird's body weight, with guidance from an experienced avian veterinarian essential for safe and effective treatment. The extreme variation in body size among bird species means that a dose appropriate for a large macaw would be vastly different from that needed for a small finch, and errors in dosing could result in either treatment failure or toxicity. Commercial selamectin products are formulated at concentrations designed for dogs and cats, and veterinarians must calculate appropriate volumes for avian patients based on the specific product concentration and the bird's weight in grams. Bird owners should never attempt to dose selamectin independently.

The typical dosing range for selamectin in birds generally falls between 6 to 18 mg/kg body weight, though specific doses vary based on the parasite being treated, the bird species, and veterinary judgment. Some practitioners prefer doses at the lower end of this range for routine external parasite treatment, while higher doses may be employed for more resistant parasites or internal parasites like air sac mites. The veterinarian will determine the optimal dose based on the clinical situation, taking into account any factors that might affect drug handling or sensitivity in the individual patient.

Treatment duration and repeat treatment intervals depend on the type of parasite being addressed and the severity of infestation. For many external parasites, a single application of selamectin provides several weeks of protection and may be sufficient for elimination. However, for more persistent infestations or for parasites like air sac mites, repeat treatments at intervals of two to four weeks may be recommended to ensure complete elimination of all parasite life stages. The avian veterinarian will establish an appropriate treatment schedule and recommend follow-up evaluation to assess treatment success.

Administration of selamectin to birds involves topical application of the calculated dose to a small area of skin where the bird cannot easily preen it off. The most common application site is the skin on the back of the neck, between the shoulders. The feathers should be parted to expose bare skin, and the medication applied directly to the skin surface. Proper application technique is important for absorption, as medication applied to feathers rather than skin may not be effectively absorbed. The bird should not be bathed or heavily misted for at least 24 to 48 hours following application to allow adequate absorption.

If a scheduled selamectin treatment is missed, the avian veterinarian should be contacted for guidance on how to proceed. In general, treatment can be applied when the omission is recognized, with subsequent treatments scheduled from that point. However, significant delays may require reassessment of the treatment plan, particularly if parasite symptoms have worsened. Owners should maintain communication with the veterinarian regarding treatment progress and any concerns about scheduling.

Completing the recommended treatment protocol is essential for successful parasite elimination. Even if clinical improvement is apparent after the first treatment, additional applications may be necessary to address parasites at different life stages or to prevent rapid reinfestation. Stopping treatment prematurely can allow remaining parasites to repopulate, potentially leading to recurrent infestation. The veterinarian may recommend follow-up examination to confirm treatment success and determine whether additional applications are warranted.

Selamectin is generally well tolerated by most bird species when used at appropriate doses under veterinary supervision, and the majority of avian patients complete treatment without experiencing significant adverse effects. The safety profile of selamectin in birds has been established through clinical use and published case reports over many years. However, as with any medication, side effects can occur, and bird owners should be aware of potential reactions and know when to seek veterinary attention. Careful observation during the treatment period allows for early detection of any problems.

The most commonly observed effects following selamectin application in birds are typically mild and transient. Some birds may show temporary behavioral changes such as brief agitation or increased preening in the period immediately following application, likely related to the sensation of the liquid on the skin. Mild irritation at the application site may occasionally occur but typically resolves quickly. Slight temporary lethargy has been reported in some birds following treatment but usually resolves within 24 to 48 hours. These mild effects do not generally require intervention beyond continued monitoring.

Moderate side effects, while less common, should prompt closer attention and potential veterinary consultation. More pronounced lethargy or depression persisting beyond 24 to 48 hours following treatment warrants evaluation. Decreased appetite lasting more than a day or significant changes in droppings should be noted. Some birds may show signs of local skin reaction at the application site, including redness or apparent discomfort, which may indicate sensitivity to the product. If moderate symptoms persist or worsen, the avian veterinarian should be contacted for guidance.

Serious adverse effects from selamectin in birds are rare when the medication is used appropriately but can occur with overdosing or in particularly sensitive individuals. Neurological signs including tremors, ataxia, weakness, or paralysis indicate potential toxicity and require immediate veterinary attention. Severe depression or unresponsiveness is also a serious concern. Profound respiratory changes, seizures, or collapse constitute veterinary emergencies. These serious effects are most likely to occur when products intended for larger animals are applied to birds without appropriate veterinary calculation of dose, resulting in massive overdose.

Certain birds may have individual sensitivity to selamectin or may be more susceptible to adverse effects due to underlying health conditions. Young birds, geriatric birds, or birds that are debilitated may handle the medication differently than healthy adults. Any unusual symptoms following treatment should be reported to the avian veterinarian, even if the connection to the medication seems uncertain. Maintaining records of treatment dates and any observed effects provides valuable information for ongoing care and future treatment decisions.

Selamectin should not be used in birds with known hypersensitivity or previous adverse reactions to selamectin or other macrocyclic lactone compounds including ivermectin and moxidectin. While allergic reactions to these medications are relatively uncommon in birds, any bird that has experienced significant adverse effects following macrocyclic lactone administration should be considered at increased risk for similar reactions to selamectin. Cross-reactivity between compounds in this drug class is possible, and alternative treatments should be selected for sensitive individuals. Complete disclosure of previous medication reactions to the avian veterinarian enables appropriate treatment selection.

Birds with compromised liver function require careful evaluation before selamectin administration. The liver plays a role in drug metabolism, and hepatic disease or dysfunction could potentially alter how selamectin is processed in the body. Birds with known liver problems should be assessed individually, and the veterinarian may recommend liver function testing or alternative treatments depending on the severity of hepatic compromise. Similarly, birds with significant kidney disease warrant careful consideration, as renal function affects drug elimination from the body.

Breeding birds and those actively laying eggs should be evaluated carefully before selamectin treatment, as the effects of this medication on avian reproduction have not been fully characterized. While selamectin has been used in breeding situations when benefits clearly outweigh potential risks, the decision requires careful consideration by the avian veterinarian. Some practitioners prefer to time treatments outside of active breeding periods when possible, or may recommend alternative treatments for actively breeding birds. Potential transfer of medication to developing embryos through treated eggs is a consideration that should be discussed.

Very young birds, particularly nestlings and recently fledged juveniles, may require additional caution with selamectin use. The metabolism and drug handling capabilities of very young birds may differ from adults, potentially affecting both efficacy and safety. The blood-brain barrier may be less developed in very young birds, theoretically increasing the risk of neurological effects. Additionally, severely debilitated, dehydrated, or systemically ill birds may be at increased risk for adverse effects and may benefit from stabilization before antiparasitic treatment is initiated. The avian veterinarian will assess each patient individually to determine appropriate treatment timing and approach.

Informing the avian veterinarian about all medications, supplements, and treatments the bird is currently receiving or has recently received is essential before starting selamectin therapy. Drug interactions can potentially affect the safety or efficacy of selamectin, and complete information enables the veterinarian to make appropriate prescribing decisions. This includes prescription medications, over-the-counter products, vitamins, supplements, and any other substances being administered to the bird.

Significant interactions may occur between selamectin and other macrocyclic lactone antiparasitics such as ivermectin or moxidectin. Using multiple medications from this class concurrently or in close succession could result in additive effects and increase the risk of toxicity. Avian veterinarians typically avoid combining these medications and will ensure appropriate intervals between treatments if different macrocyclic lactones are needed sequentially. Other antiparasitic medications, including organophosphates and certain other insecticides, may also interact with selamectin and should not be used concurrently without veterinary guidance.

Certain medications that affect liver enzyme activity could theoretically influence selamectin metabolism. Drugs that inhibit hepatic enzymes might slow selamectin breakdown, potentially leading to higher and more prolonged blood levels. Conversely, enzyme-inducing medications could potentially accelerate metabolism. While specific interaction data in birds is limited, the veterinarian will consider potential metabolic interactions when prescribing selamectin to birds receiving other medications. This is particularly relevant for birds on long-term treatments for chronic conditions.

Supplements and dietary factors are generally not expected to have major interactions with topically applied selamectin, but complete disclosure of the bird's supplement regimen remains appropriate. Some owners use various natural products for parasite control, and these should be mentioned when discussing treatment options. Probiotics are generally considered safe to continue during selamectin treatment. The veterinarian can provide specific guidance on any supplement adjustments that might be advisable during the treatment period.

Monitoring for signs of drug interactions should continue throughout treatment and for several weeks following application given selamectin's prolonged activity. If the bird is receiving ongoing medications for chronic conditions and any changes in response to those medications are noted, this should be reported to the veterinarian. Signs that might suggest interaction include unexpected side effects, changes in effectiveness of concurrent medications, or any unusual symptoms. The veterinarian can investigate whether such changes might be interaction-related and adjust treatment accordingly.

General precautions for selamectin use in birds emphasize the critical importance of accurate dosing based on current body weight and strict adherence to veterinary instructions. Given the enormous size variation among bird species, from tiny finches to large macaws, and the concentrated formulations of commercial selamectin products designed for larger animals, dosing errors represent the greatest risk factor for adverse effects. Birds must be weighed accurately immediately before treatment, and the veterinarian should calculate the appropriate dose based on the specific product concentration. Owners should never attempt to estimate doses or use products without veterinary guidance.

Species-specific sensitivity to selamectin may exist, though comprehensive comparative data across all bird species is not available. Some practitioners exercise additional caution with certain species based on anecdotal reports or theoretical concerns. When treating species for which the veterinarian has less experience with selamectin, conservative dosing and careful monitoring may be advisable. Any adverse reactions should be documented and reported to contribute to the collective knowledge of avian drug responses. The veterinarian's familiarity with specific species pharmacology guides treatment decisions.

Application technique affects both the safety and efficacy of selamectin treatment. The medication should be applied directly to skin rather than feathers to ensure proper absorption, which requires careful parting of feathers at the application site. The back of the neck between the shoulders is the preferred location as birds cannot easily preen this area. The medication should not be applied to irritated, broken, or diseased skin. Following application, birds should be prevented from bathing or being heavily misted for at least 24 to 48 hours to allow adequate absorption before any water exposure.

Monitoring birds during the period following selamectin application allows for early detection of any adverse effects or treatment response. Signs of treatment success include reduction in scratching, preening, and other behaviors associated with parasite irritation, along with improvement in feather condition over time. Conversely, any signs of toxicity such as neurological changes, profound lethargy, or other concerning symptoms should prompt immediate veterinary contact. Keeping records of treatment dates, doses, and observations assists in ongoing management and future treatment planning.

Special populations requiring additional consideration include geriatric birds, whose organ function may be diminished, and juvenile birds, whose drug metabolism may differ from adults. Immunocompromised birds, including those with concurrent illness or chronic disease, may be at increased risk for both parasitic disease severity and treatment complications. Birds that are significantly underweight or debilitated may require dose adjustment or delayed treatment until their condition improves. The avian veterinarian will factor these considerations into treatment planning and monitoring recommendations.

Proper storage of selamectin products maintains medication stability and ensures effectiveness when used. Commercial selamectin formulations should be stored according to label directions, typically at controlled room temperature away from extreme heat or cold. The products should be kept in their original packaging until use, as the packaging protects against light exposure that could degrade the active ingredient. Storage locations should be secure from children, pets, and the birds being treated to prevent accidental exposure. The expiration date should be observed, and expired products should not be used.

Selamectin products are typically packaged in single-dose applicator tubes designed for easy application. Once opened, these tubes should generally be used immediately, as the medication may not remain stable after the seal is broken. If the veterinarian has provided specific instructions for partial tube use in very small birds, any storage recommendations provided should be followed exactly. Discoloration, precipitation, or other visible changes in the product may indicate degradation, and affected products should not be used. When in doubt about product integrity, consult the veterinarian or pharmacist.

Safe handling of selamectin protects both human handlers and prevents accidental exposure of non-target animals. While selamectin has relatively low toxicity to mammals, minimizing unnecessary exposure is appropriate. Handlers should avoid getting the medication on their skin and should wash hands thoroughly after application. The product should not be ingested, and contact with eyes should be avoided. If accidental skin exposure occurs, the area should be washed with soap and water. If accidental eye exposure occurs, the eye should be flushed with water and medical attention sought if irritation persists.

Disposal of unused selamectin should follow local regulations for pharmaceutical waste disposal. Single-dose tubes that have been used should be disposed of properly rather than retained. Unused or expired products should not be flushed down toilets or drains, as macrocyclic lactones can be toxic to aquatic organisms. Many communities offer pharmaceutical take-back programs through pharmacies or municipal hazardous waste facilities. If no take-back program is available, consult local guidelines for appropriate disposal methods. Empty packaging can typically be disposed of with regular household waste after ensuring no product residue remains.

The response to selamectin can vary among different bird species due to metabolic differences, body composition, and inherent sensitivities, making species-specific considerations an important aspect of treatment planning. Avian veterinarians draw on published literature, clinical experience, and knowledge of comparative pharmacology when recommending selamectin treatment for specific species. While selamectin has been used safely across a broad range of avian species, some variation in optimal dosing and sensitivity exists. The veterinarian's expertise with the specific species being treated helps ensure safe and effective use.

Psittacine birds, including the diverse parrot family from budgerigars to macaws, are commonly treated with selamectin and generally tolerate the medication well when appropriately dosed. This group represents perhaps the best-characterized population for selamectin use in avian medicine, with substantial clinical experience supporting safety and efficacy. The enormous size range within psittacines, from small parrotlets to large macaws, requires careful attention to dose calculation for each individual. Some practitioners have particular experience with specific psittacine species and may have refined dosing recommendations based on that experience.

Passerine birds, including finches, canaries, and various softbills, present particular challenges for selamectin dosing due to their small body size. The tiny weights of many passerines mean that the volumes of medication required are very small, demanding precise measurement and careful application technique. Some veterinarians dilute commercial products to allow more accurate dosing of very small birds, while others use undiluted product in carefully calculated minute volumes. The small size of these birds also makes them potentially more susceptible to the effects of any dosing errors. Despite these challenges, selamectin is commonly used successfully in passerines for conditions including air sac mites.

Size considerations transcend species groupings and represent a fundamental factor in selamectin therapy. Very small birds require extremely precise dose calculations and careful application technique to avoid both underdosing and overdosing. Larger birds allow somewhat more margin for dosing variation but still require appropriate calculation. The relationship between body weight and drug distribution may differ between very small and large birds, potentially affecting optimal dosing strategies. The avian veterinarian's experience with birds across the size spectrum helps inform appropriate treatment approaches for each individual patient.

Several related medications within the macrocyclic lactone class provide alternatives to selamectin for avian parasite management. Ivermectin, the original and most extensively studied macrocyclic lactone in avian medicine, remains a widely used option with proven efficacy against numerous internal and external parasites. Moxidectin offers similar spectrum of activity with particularly prolonged duration of action. These related medications share the same basic mechanism of action as selamectin and are effective against many of the same parasites. The choice among macrocyclic lactones often depends on veterinary preference, formulation availability, and specific patient factors.

Alternative drug classes may be considered when macrocyclic lactones are contraindicated or when different approaches are needed. Pyrethrin and permethrin products work through different mechanisms and may be useful for external parasite control, particularly environmental treatment. For internal parasites other than those susceptible to macrocyclic lactones, medications such as fenbendazole or praziquantel target specific parasite types. When resistance to macrocyclic lactones is suspected, alternative drug classes may be necessary. The veterinarian will select the most appropriate treatment based on the specific parasites involved, the bird's health status, and any relevant contraindications.

Complementary therapies support antiparasitic treatment and contribute to overall parasite management success. Environmental decontamination is essential for preventing reinfestation, particularly for parasites that can survive in the environment between hosts. Thorough cleaning and treatment of cages, perches, and bird room areas should accompany medication therapy. Nutritional support helps debilitated birds recover from parasitic disease, and probiotic supplementation may support gastrointestinal health, particularly in birds that have been unwell. Husbandry improvements that reduce parasite transmission risk, such as quarantine protocols for new birds and regular health monitoring, complement medical treatment. The avian veterinarian can provide guidance on comprehensive parasite management strategies that combine appropriate medication with environmental and husbandry measures.